Momentact 200 mg - analgesic anti-inflammatory - 36 coated tablets

Product Description

Moment 200mg 

Moment is used in the treatment of pain of various origins and nature (headache, toothache, neuralgia, osteoarticular and muscular pain, menstrual pain). It is an adjuvant in the symptomatic treatment of fever and flu.

Dosage and Directions for Use

Moment is administered according to the following doses:

• Adults and children over 12 years: 1-2 tablets, 2-3 times a day.

Do not exceed the dose of 6 tablets per day. Do not exceed the recommended doses; elderly patients in particular should stick to the minimum doses indicated above. Take the product on a full stomach.

Contraindications

• Do not administer to children under 12 years of age.
• Pregnancy and breastfeeding.
• Hypersensitivity to the active ingredient, to other antirheumatics (acetylsalicylic acid, etc.) or to any of the excipients. Active or severe gastroduodenal ulcer or other gastropathies.
• History of gastrointestinal bleeding or perforation related to previous active treatments or history of recurrent peptic ulcer/hemorrhage (two or more distinct episodes of proven ulceration or bleeding).
• Severe hepatic or renal insufficiency.
• Severe cardiac insufficiency.

Special warnings

Use caution in patients whose activity requires vigilance if they notice drowsiness, dizziness, or depression during therapy with ibuprofen. The use of the drug, as with any drug inhibiting the synthesis of prostaglandins and cyclooxygenase, is not recommended in women intending to become pregnant. Administration should be suspended in women who have fertility problems or who are undergoing investigations of fertility. The use of the medicine should be avoided in conjunction with NSAIDs, including selective COX-2 inhibitors.

Undesirable effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms. Clinical trial and epidemiological data suggest that use of ibuprofen, particularly at high doses (2400 mg/day) and in long-term treatment, may be associated with a small increased risk of arterial thrombotic events (for example, myocardial infarction or stroke).

Pregnancy and breastfeeding

• Pregnancy

Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/foetal development. Results of epidemiological studies suggest an increased risk of miscarriage, cardiac malformation, and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk of cardiac malformations increased from less than 1% to approximately 1.5%.

The risk is believed to increase with dose and duration of therapy. In animals, administration of prostaglandin synthesis inhibitors has been shown to result in increased pre- and post-implantation loss and embryo-fetal mortality. Furthermore, an increased incidence of various malformations, including cardiovascular, has been reported in animals administered prostaglandin synthesis inhibitors during the organogenetic period.

During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the fetus to: cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension), renal dysfunction, which may progress to renal failure with oligo-hydroamniosis, the mother and the newborn.
At the end of pregnancy, to: possible prolongation of bleeding time, and antiplatelet effect which may occur even at very low doses, inhibition of uterine contractions resulting in delayed or prolonged labor.

Expiry and storage

Check the expiry date indicated on the package. The expiry date indicated on the package refers to the product in its intact packaging, correctly stored. Store below 25°C.

Warning: Do not use the medicine after the expiry date shown on the package.

Composition

Moment Tablets contain:
Active ingredient: ibuprofen 200 mg
Excipients: l-arginine, sodium bicarbonate, sodium bitartrate, lactose, sodium saccharin, grapefruit flavoring, crospovidone.

Format

Pack with 36 coated tablets.